Skip to main content
Equibles
ABEO logo

ABEO · Abeona Therapeutics Inc. · Analyst Estimates

Track ABEO — free

Use ABEO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ABEO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.45 +0.14 (+3.25%) At close · Oct 27 Q1 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$255.33M
Shares
57.18M
Volume · Oct 27 663.68K Avg daily vol (3M) 1.36M

Analyst Estimates

Compare analyst forecasts for Abeona Therapeutics Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-14 15:57 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.15
-0.95
-0.72
4
-0.84
-0.87
-0.68
-0.68
1
1
0
0
Revenue
USD
Publication date not stated
42.98M
52.63M
66.00M
8
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.83
-0.21
0.42
4
-0.035
-0.19
0.29
0.29
0
0
0
0
Revenue
USD
Publication date not stated
79.00M
115.62M
156.00M
8
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.25
-0.17
-0.05
4
-0.11
-0.13
-0.11
-0.11
0
0
0
0
Revenue
USD
Publication date not stated
11.39M
14.82M
21.60M
8
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.24
-0.13
-0.02
4
-0.075
-0.093
-0.053
-0.053
1
1
0
0
Revenue
USD
Publication date not stated
10.17M
17.70M
24.30M
8
 — — — — — — — —
Key facts CIK 318306 CUSIP 00289Y206 13F (30d) 15 filings 15 filers Visit website Investor relations